Federal contract award
75N91025F00001
AMRVS REQUIRES THE PRODUCTION OF VARIOUS REAGENTS/IMMUNOGENS WITH A PURITY/QUALITY GRADE SUITABLE FOR PRECLINICAL STUDIES IN NON-HUMAN PRIMATES. THESE REAGENTS WILL ASSIST IN PREVENTING HTLV-1 AND HIV INFECTION BY FACILITATING THE DEVELOPMENT OF EFFE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541380 — Testing Laboratories and Services |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | 75N91024D00015 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $74.6K |
| Current contract value | $74.6K |
| Potential contract value / ceiling | $74.6K |
| Start date | Sep 30, 2025 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Sep 29, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 29, 2025 | 0 | $74.6K | AMRVS REQUIRES THE PRODUCTION OF VARIOUS REAGENTS/IMMUNOGENS WITH A PURITY/QUALITY GRADE SUITABLE FOR PRECLINICAL STUDIES IN NON-HUMAN PRIMATES. THESE REAGENTS WILL ASSIST IN PREVENTING HTLV-1 AND HIV INFECTION BY FACILITATING THE DEVELOPMENT OF EFFE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.